.
, , . , ( ). . . , , . , , . , 10-20% , , . , , . , -, , - : , , . , , .
"" | ||
, | , | |
, |
, . , , . , : + = .
.
, : , , , , . . , , , - , , . , .
:
1. : , , , , ; , .
|
|
2. - ; . " " , . . , .
.
, ; , , .
, .
, .
.
, .
, , , .
.
. 5- 12% . 70%. (5- 30-50%).
.
, , .
, .
, .
(, ). .
, .
.
.
25-40% , . ; , (5-, , ) .
|
|
.
, 5- 2-3 ( ). (www.nih.gov/icd) 5- .
(Philip Rubin, Clinical Oncology, 1993).
1 T1 N2 M0 T1N1M0 T2 N0M0 | |||
2 T1N2M0, T2 N1 T3 N0 | |||
3 T2 N2 T3 N1 T4 N0 T3 N2 T4 N1 | 45-50 | - multiagent chemotherapy | |
4 T4 N2 Tany Nany M1 | 45-50 45-50 |
.
, , . , 5- 70%. , . 40% .
.
1. . , , .
2. . . , , 1967
3. Ph. Rubin. Clinical Oncology, A Multidisciplinary Approach for Physicians and Students, 7th Edition, 1993
4. , , .. . , 1997 .